CIRM provides funding across five key areas: Infrastructure, Education, Discovery Research, Translational Research, and Clinical Research. By supporting projects at every stage of development, from initial discovery to clinical trials, CIRM drives progress in regenerative medicine and accelerates innovative therapies to patients.
Check out our portfolio of awards below.
All CIRM Grants
Search Filters »
| Institution |
Researcher name |
Grant Type |
Grant Title |
Award Value |
| University of California, San Diego |
Gene Wei-Ming Yeo |
Basic Biology IV |
Stem cell models to analyze the role of mutated C9ORF72 in neurodegeneration |
$1,260,360 |
| Cedars-Sinai Medical Center |
Professor Clive Niels Svendsen |
iPSC Consortia Award |
The HD iPSC Consortium: Repeat Length Dependent Phenotypes for Assay Development |
$300,000 |
| Stanford University |
Dr. Joseph C. Wu |
Disease Team Therapy Development – Research |
Human Embryonic Stem Cell-Derived Cardiomyocytes for Patients with End Stage Heart Failure |
$19,060,330 |
| Capricor, Inc |
Dr. Rachel Ruckdeschel Smith |
Disease Team Therapy Development – Research |
Allogeneic Cardiac-Derived Stem Cells for Patients Following a Myocardial Infarction |
$14,405,857 |
| University of California, Los Angeles |
Dr. Antoni Ribas MD/PhD |
Disease Team Therapy Development – Research |
Genetic Re-programming of Stem Cells to Fight Cancer |
$14,144,221 |
| University of California, Los Angeles |
Dr. Stanley Nelson |
Disease Team Therapy Development – Research |
Combination Therapy to Enhance Antisense Mediated Exon Skipping for Duchenne Muscular Dystrophy |
$0 |
| University of California, Irvine |
Dr. Henry John Klassen |
Disease Team Therapy Development – Research |
Retinal progenitor cells for treatment of retinitis pigmentosa |
$17,144,825 |
| Cedars-Sinai Medical Center |
Professor Clive Niels Svendsen |
Disease Team Therapy Development – Research |
Progenitor Cells Secreting GDNF for the Treatment of ALS |
$16,168,464 |
| StemCells, Inc. |
Dr. Alexandra Capela |
Disease Team Therapy Development – Research |
Restoration of memory in Alzheimer’s disease: a new paradigm using neural stem cell therapy |
$8,901,641 |
| Stanford University |
Dr. Judith A Shizuru |
Disease Team Therapy Development – Research |
A monoclonal antibody that depletes blood stem cells and enables chemotherapy free transplants |
$18,990,683 |
| University of California, Davis |
Dr. John Laird |
Disease Team Therapy Development – Research |
Phase I study of IM Injection of VEGF-Producing MSC for the Treatment of Critical Limb Ischemia |
$3,728,384 |
| University of California, Davis |
Dr. Vicki Wheelock |
Disease Team Therapy Development – Research |
MSC engineered to produce BDNF for the treatment of Huntington’s disease |
$8,924,235 |
| StemCells, Inc. |
Dr. Nobuko Uchida |
Disease Team Therapy Development – Research |
Neural stem cell transplantation for chronic cervical spinal cord injury |
$0 |
| University of California, Davis |
Nancy E. Lane |
Disease Team Therapy Development – Research |
Treatment of non-traumatic osteonecrosis with endogenous Mesenchymal stem cells |
$18,227,898 |
| Salk Institute for Biological Studies |
Dr. David R Schubert |
Early Translational III |
Stem cell based small molecule therapy for Alzheimer’s disease |
$1,673,757 |
| City of Hope, Beckman Research Institute |
Dr. Stephen J Forman |
Early Translational III |
Targeting glioma cancer stem cells with receptor-engineered self-renewing memory T cells |
$5,215,447 |
| Gladstone Institutes, J. David |
Dr. Deepak Srivastava |
Early Translational III |
Direct Cardiac Reprogramming for Heart Regeneration |
$5,795,871 |
| University of California, San Diego |
Dr. Lawrence S. B. Goldstein |
Early Translational III |
Identifying Drugs for Alzheimer’s Disease with Human Neurons Made From Human IPS cells |
$1,774,420 |
| University of California, San Diego |
Dr. Yang Xu |
Early Translational III |
Human ES cell based therapy of heart failure without allogenic immune rejection |
$1,857,600 |
| Stanford University |
Dr. Joseph C. Wu |
Early Translational III |
Heart Repair with Human Tissue Engineered Myocardium |
$4,395,080 |
| University of California, San Francisco |
Mort Cowan |
Early Translational III |
Gene Correction of Autologous Hematopoietic Stem Cells in Artemis Deficient SCID |
$3,862,367 |
| Stanford University |
Professor Helen M. Blau PhD |
Early Translational III |
Local Delivery of Rejuvenated Old Muscle Stem Cells to Increase Strength in Aged Patients |
$1,825,283 |
| University of Southern California |
Dr. Toshio Miki |
Early Translational III |
Generation of hepatic cell from placental stem cell for congenital metabolic disorders |
$1,750,375 |
| Children’s Hospital of Orange County |
Dr. Philip H Schwartz |
Early Translational III |
Immune-Matched Neural Stem Cell Transplantation for Pediatric Neurodegenerative Disease |
$4,266,015 |
| University of California, San Francisco |
Dr. Holger F Willenbring |
Early Translational III |
Generation of safe and therapeutically effective human induced hepatocyte-like cells |
$1,544,170 |
| Salk Institute for Biological Studies |
Juan Carlos Izpisua Belmonte |
Early Translational III |
Direct reprogramming towards vascular progenitors for the treatment of ischemia |
$2,340,000 |
| University of California, San Diego |
Dr. Eric D. Adler MD |
Early Translational III |
Identification of Novel Therapeutics for Danon Disease Using an iPS Model of the Disease |
$1,701,575 |
| University of California, Davis |
Walter Douglas Boyd |
Early Translational III |
Extracellular Matrix Bioscaffold Augmented with Human Stem Cells for Cardiovascular Repair |
$4,631,754 |
| Stanford University |
Dr. Bertha Chen |
Early Translational III |
Autologous iPSC Therapy for Urinary Incontinence |
$4,715,738 |
| University of California, San Diego |
Mark H Tuszynski |
Early Translational III |
Functional Neural Relay Formation by Human Neural Stem Cell Grafting in Spinal Cord Injury |
$4,600,447 |
| University of California, Davis |
Prof. Kyriacos A. Athanasiou Ph.D |
Early Translational III |
Tissue engineered cartilage from autologous, dermis-isolated, adult, stem (DIAS) cells |
$1,735,703 |
| University of California, Irvine |
Craig M. Walsh |
Early Translational III |
Multiple Sclerosis therapy: Human Pluripotent Stem Cell-Derived Neural Progenitor Cells |
$4,535,005 |
| Scripps Research Institute |
Peter G. Schultz |
Early Translational III |
Targeting Stem Cells to Enhance Remyelination in the Treatment of Multiple Sclerosis |
$2,559,333 |
| University of California, San Francisco |
Dr. Arnold Kriegstein |
Early Translational III |
Human ES cell-derived MGE inhibitory interneuron transplantation for spinal cord injury |
$1,623,251 |
| University of California, San Diego |
Gene Wei-Ming Yeo |
Early Translational III |
Molecules to Correct Aberrant RNA Signature in Human Diseased Neurons |
$1,532,323 |
| University of California, Santa Cruz |
Dr. David Haussler |
Training Grant I-3 |
Training Program in Systems Biology of Stem Cells |
$1,133,701 |
| University of California, Santa Barbara |
Dr. Dennis O. Clegg |
Training Grant I-3 |
UCSB Stem Cell Biology Training Program |
$975,334 |
| Salk Institute for Biological Studies |
Juan Carlos Izpisua Belmonte |
Training Grant I-3 |
Training in the Biology of Human Enbryonic Stem Cells and Emerging Technologies |
$1,261,333 |
| California Institute of Technology |
Paul H. Patterson |
Training Grant I-2 |
Training in Stem Cell Biology at CIT |
$1,817,214 |
| Children’s Hospital of Los Angeles |
Dr. Donald B. Kohn |
Training Grant I-2 |
Training Grant 1 |
$2,173,872 |
| Sanford Burnham Prebys Medical Discovery Institute |
Dr. Mark Mercola |
Training Grant I-2 |
Burnham Institute CIRM Stem Cell Training Grant (Type II) |
$1,061,865 |
| Gladstone Institutes, J. David |
Dr. Robert W Mahley |
Training Grant I-2 |
Gladstone CIRM Scholar Program |
$2,192,073 |
| Scripps Research Institute |
Peter G. Schultz |
Training Grant I-2 |
Training Grant I |
$1,021,395 |
| University of California, Davis |
Dr. Frederick J Meyers MD |
Training Grant I-1 |
Stem Cell Research Training Grant |
$1,780,859 |
| University of California, San Francisco |
Dr. Susan J Fisher PhD |
Training Grant I-1 |
Training Grant I |
$2,868,145 |
| University of California, Los Angeles |
Dr. Owen N Witte M.D. |
Training Grant I-1 |
CIRM Type I Comprehensive Training Program |
$3,660,398 |
| University of Southern California |
Dr. Robert E Maxson |
Training Grant I-1 |
CIRM Stem Cell Biology Training Grant |
$2,332,431 |
| University of California, Irvine |
Dr. Peter Bryant |
Training Grant I-1 |
Stem Cell Research Training Grant |
$1,935,487 |
| University of California, Berkeley |
Randy W. Schekman |
Training Grant I-1 |
Human Stem Cell Training at UC Berkeley and Childrens Hospital of Oakland |
$2,360,457 |
| University of California, San Diego |
Dr. Lawrence S. B. Goldstein |
Training Grant I-1 |
Interdisciplinary Stem Cell Training Program at UCSD |
$3,459,396 |
